Evidence map›Paper›PMID 31382682›Full record

ReviewAntioxidants (Basel, Switzerland)2019

Yong Chool Boo

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 257 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Bioactive Compounds Isolated from the Species of theMolecules (Basel, Switzerland) · 2025
    Review
  20. Phenolic-Rich Extracts ofPlants (Basel, Switzerland) · 2025
    Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Yong Chool BooDepartment of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea. ycboo@knu.ac.kr.ORCID 0000-0001-9895-2066
Kyungpook National University · KR

Funding

National Research Foundation of Korea No. 2019R1I1A2A01045132
6 · The paper itself

Abstract

Controlling unwanted hyperpigmentation is a major challenge in dermatology and cosmetology, and safe and efficacious antimelanogenic agents are deemed useful for this purpose.

Indexed as

4-hydroxycinnamic acidantioxidantcosmeticsinflammationmelaninoxidative stressp-coumaric acidphytochemicalpigmentationskinUV

Identifiers

PMID31382682
PMCPMC6720745
OpenAlexW2965560392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.